These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 18523872
1. Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions. Muenster U, Grieshop B, Ickenroth K, Gnoth MJ. Pharm Res; 2008 Oct; 25(10):2320-6. PubMed ID: 18523872 [Abstract] [Full Text] [Related]
5. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening. Ye D, Harder A, Fang Z, Weinheimer M, Laplanche L, Mezler M. Pharm Res; 2020 Sep 11; 37(10):194. PubMed ID: 32918191 [Abstract] [Full Text] [Related]
7. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Allen JD, van Loevezijn A, Lakhai JM, van der Valk M, van Tellingen O, Reid G, Schellens JH, Koomen GJ, Schinkel AH. Mol Cancer Ther; 2002 Apr 11; 1(6):417-25. PubMed ID: 12477054 [Abstract] [Full Text] [Related]
8. Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein. Fujita Y, Noguchi K, Suzuki T, Katayama K, Sugimoto Y. BMC Res Notes; 2013 Nov 06; 6():445. PubMed ID: 24196382 [Abstract] [Full Text] [Related]
10. In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2. Marchetti S, Oostendorp RL, Pluim D, van Eijndhoven M, van Tellingen O, Schinkel AH, Versace R, Beijnen JH, Mazzanti R, Schellens JH. Mol Cancer Ther; 2007 Dec 06; 6(12 Pt 1):3307-13. PubMed ID: 18089724 [Abstract] [Full Text] [Related]
13. Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells. Karla PK, Earla R, Boddu SH, Johnston TP, Pal D, Mitra A. Curr Eye Res; 2009 Jan 06; 34(1):1-9. PubMed ID: 19172464 [Abstract] [Full Text] [Related]
14. Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein. Liu H, Huang L, Li Y, Fu T, Sun X, Zhang YY, Gao R, Chen Q, Zhang W, Sahi J, Summerfield S, Dong K. Drug Metab Dispos; 2017 May 06; 45(5):449-456. PubMed ID: 28209803 [Abstract] [Full Text] [Related]
15. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. Jonker JW, Smit JW, Brinkhuis RF, Maliepaard M, Beijnen JH, Schellens JH, Schinkel AH. J Natl Cancer Inst; 2000 Oct 18; 92(20):1651-6. PubMed ID: 11036110 [Abstract] [Full Text] [Related]
16. Using the lentiviral vector system to stably express chicken P-gp and BCRP in MDCK cells for screening the substrates and studying the interplay of both transporters. Zhang Y, Huang J, Liu Y, Guo T, Wang L. Arch Toxicol; 2018 Jun 18; 92(6):2027-2042. PubMed ID: 29725709 [Abstract] [Full Text] [Related]
18. The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2). Kannan P, Telu S, Shukla S, Ambudkar SV, Pike VW, Halldin C, Gottesman MM, Innis RB, Hall MD. ACS Chem Neurosci; 2011 Feb 16; 2(2):82-9. PubMed ID: 22778859 [Abstract] [Full Text] [Related]
19. Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier. Li Y, Wu Q, Li C, Liu L, Du K, Shen J, Wu Y, Zhao X, Zhao M, Bao L, Gao J, Keep RF, Xiang J. PLoS One; 2016 Feb 16; 11(6):e0157576. PubMed ID: 27300692 [Abstract] [Full Text] [Related]
20. Interactions of cyclosporin a with breast cancer resistance protein. Xia CQ, Liu N, Miwa GT, Gan LS. Drug Metab Dispos; 2007 Apr 16; 35(4):576-82. PubMed ID: 17220244 [Abstract] [Full Text] [Related] Page: [Next] [New Search]